Key facts
- Garland Surgical’s last known valuation is $2.5M (Jun 2023).
- It has raised $3.8M; the latest was Seed Round ($2.9M) in Jul 2025.
- Notable investors include Innovate UK, NLC Health Ventures, ScaleUps Ventures, BetaDen, L-Università ta' Malta — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Garland Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Garland Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Garland Surgical
Manufacture of medical implants and supplies intended to improve the range of motion of the hip. The company offers hip joint prosthesis, which exhibits drastically reduced wear, helps with the high dislocation risk, and enhances lifespan and functionality, enabling medical professionals to make the surgical assembly procedure easier and enhance the quality of life of many patients.
- Sector
- Healthcare
- HQ
- Worcester, United Kingdom
- Employees
- 7
- Website
- garlandsurgical.health/
- Ownership
- Privately Held (backing)
Garland Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Garland Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Garland Surgical in its N-PORT filings yet. We sweep new filings monthly.